I-BiTTM game
Device30 minutes intervention weekly for 6 weeks.
NCT Number: NCT01702727
The study aims to determine whether 30 minutes of treatment playing an interactive computer game weekly for 6 weeks, improves visual acuity. The game has been specially configured to ensure the amblyopic eye is preferentially stimulated and the patient wears shutter glasses which manipulate the image seen by each eye in order to provide more information to the amblyopic eye. Patients will be randomised to play the computer game using the I-BiTTM technology, play the computer game but without the I-BiTTM technology, or watch a DVD using the I-BiTTM technology.
Looking for future studies?
Notify Me4 year–8 year
All sexes
Interventional
Phase 2
Cambridge University Hospitals NHS Trust, Cambridge, Cambridgeshire, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 minutes intervention weekly for 6 weeks.
30 minutes intervention weekly for 6 weeks.
30 minutes intervention weekly for 6 weeks.
Time frame: 6 weeks
Time frame: 10 weeks
Nottingham University Hospitals NHS Trust
Other
Evaluation and Development of a Novel Binocular Treatment (I-BiTTM) System Using Video Clips and Interactive Games to Improve Vision in Children With Amblyopia ('Lazy Eye').
Acronym: I-BiT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02983552
Amblyopia, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05732467
Amblyopia, Brain Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT06372548
Adherence, Treatment, Amblyopia
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07437807
Amblyopia, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial Details